Your login
Your password
Confirm your password
Your email
I agree to receive the R3i newsletter
Yes No

R3I Events

24 November 2018

The Selective Peroxisome Proliferator-Activated Receptor Alpha Modulator (SPPARMa) Concept

"Accreditation by AACI confirms R3i is to be trusted in the field of Residual Vascular Risk."

The information provided on this website is for educational purposes only and cannot be used for personal medical care. Always seek the advice of a qualified health professional if you have any questions regarding diagnosis and/or management of your specific condition.

Residual Risk Reduction Initiative
Picassoplatz 8
4010 Basel
Switzerland